← Eichor
Condition: Lung Transplant Rejection Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Lung Transplant Rejection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Developing Hyperpolarized Gas MRI Signatures to Detect and Manage Acute Cellular Rejection
Phase 2 · 1 location(s) · University of Virginia · NCT07046910LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
Phase 2 · 1 location(s) · Steven Hays, MD · NCT06018766Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients
Phase N/A · 1 location(s) · Northwestern University · NCT01531257Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
NA · 1 location(s) · Brigham and Women's Hospital · NCT06538376Lung Ultrasound Artefact Analysis for Exclusion of Acute Rejection in Lung Transplant Recipients
NA · 1 location(s) · Mayo Clinic · NCT04582279Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
Phase N/A · 19 location(s) · Duke University · NCT06399302Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
Phase 2 · 12 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06476132Cryoprobe Biopsy and Chronic Rejection in Lung Transplant Recipients
NA · 1 location(s) · Mayo Clinic · NCT06824402A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfun
Phase 3 · 79 location(s) · Sanofi · NCT06082037Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLAD
Phase N/A · 3 location(s) · Brian Keller · NCT07434869Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation
Phase N/A · 11 location(s) · University of Alberta · NCT02812290A Prospective Randomized Trial of ECP in Subclinical AMR
NA · 7 location(s) · Medical University of Vienna · NCT06112951A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection After Lung Transplantation
Phase 1 · 2 location(s) · Washington University School of Medicine · NCT06990711Liquid biopsiEs fOr luNg AllogRaft Damage classificatiOn - LEONARDO
Phase N/A · 1 location(s) · Jesper Magnusson · NCT06679257Diagnostic and Prognostic Biomarkers of Transplant Dysfunction in the Context of Lung Transplantation
NA · 1 location(s) · Hopital Foch · NCT04837339Noninvasive Early Detection of Lung Allograft Dysfunction After Lung Transplantation With Multiple Breath Washout Test
NA · 1 location(s) · University of Zurich · NCT05586906Safety of Endobronchial Mesenchymal Stromal Cells in the Treatment of Chronic Lung Allograft Dysfunction
Phase 1 · 1 location(s) · Instituto De Investigación Sanitaria Puerta De Hierro-Segovi · NCT06514378Exhaled Breath Particles in Lung Transplantation
Phase N/A · 1 location(s) · Lund University Hospital · NCT05375149GRAfT 2.0. A Multimodal Prospective Approach to Define the Mechanisms and Clinical Features of Acute and Chronic Rejecti
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT07516379
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.